Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexeo Therapeutics Inc. logo

Chief Medical Officer Bhalla Narinder Pal was granted 55,000 shares and sold $98,593 worth of shares (22,306 units at $4.42), increasing direct ownership by 66% to 82,194 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LXEO (Lexeo Therapeutics Inc.) and more on Quantisnow.